Anemia in Chronic Kidney Disease: HIF-PHIs May Be on the Horizon скачать в хорошем качестве

Anemia in Chronic Kidney Disease: HIF-PHIs May Be on the Horizon

Dr. Bruce Spinowitz discusses the outcome of the Fall 2022 FDA Advisory Committee meeting as it relates to the potential role of daprodustat in the future treatment algorithm for patients with anemia in chronic kidney disease. View this program in its entirety: www.ExchangeCME.com/CKDSnapShots Resources for healthcare professionals and patients: www.ExchangeCME.com/CKDClinicalResources ExchangeCME.com is an online community of more than 45,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences. By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers. Follow us on social! twitter:   / exchangecme   facebook:   / exchangecme   linkedin:   / 10863550   #CKD #anemia #chronickidneydisease #cme #CKDAnemia #HIF #hospitalmedicine #kidney #kidneydisease